omega-n-methylarginine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies ((3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid) | Trials ((3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid) | Recent Studies (post-2010) ((3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 1,459 | 368 | 396 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuhlmann, CR; Lessmann, V; Luhmann, HJ | 1 |
1 other study(ies) available for omega-n-methylarginine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chains.
Topics: Analysis of Variance; Animals; Antioxidants; Astrocytes; Biological Transport; Blood-Brain Barrier; Capillary Permeability; Cattle; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Drug Interactions; Electric Impedance; Endothelial Cells; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Mice; Microscopy, Confocal; Models, Animal; Myosin Light Chains; Nitric Oxide; omega-N-Methylarginine; Rats | 2006 |